PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Lichtenegger, F.S. ; Schnorfeil, F.M. ; Koehnke, T.* ; Altmann, T. ; Buecklein, V.* ; Moosmann, A. ; Brueggemann, M.* ; Wagner, B.* ; Hiddemann, W. ; Bigalke, I. ; Kvalheim, G.* ; Subklewe, M.

Next-generation dendritic cell vaccination in postremission therapy of AML: Results of a clinical phase I trial.

Cancer Immunol. Res. 4:B146 (2016)
Open Access Green as soon as Postprint is submitted to ZB.
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Meeting abstract
Language
Publication Year 2016
HGF-reported in Year 0
ISSN (print) / ISBN 2326-6066
e-ISSN 2326-6074
Journal Cancer Immunology Research
Quellenangaben Volume: 4, Issue: 1, Pages: , Article Number: B146 Supplement: ,
Publisher AACR
Publishing Place Philadelphia, Pa.
Reviewing status Peer reviewed
Institute(s) CCG Immunotherapy (KKG-KIT)
Research Unit Gene Vector (AGV)
POF-Topic(s) 30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
30203 - Molecular Targets and Therapies
Research field(s) Immune Response and Infection
PSP Element(s) G-520360-001
G-501500-001
WOS ID WOS:000375484400216
Erfassungsdatum 2016-06-03
[➜Report correction]